GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Change In Other Working Capital

Y-Biologics (XKRX:338840) Change In Other Working Capital : ₩-1,902 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Y-Biologics Change In Other Working Capital?

Y-Biologics's Change In Other Working Capital for the quarter that ended in Mar. 2024 was ₩146 Mil. It means Y-Biologics's Other Working Capital increased by ₩146 Mil from Dec. 2023 to Mar. 2024 .

Y-Biologics's Change In Other Working Capital for the fiscal year that ended in Dec. 2022 was ₩705 Mil. It means Y-Biologics's Other Working Capital increased by ₩705 Mil from Dec. 2021 to Dec. 2022 .


Y-Biologics Change In Other Working Capital Historical Data

The historical data trend for Y-Biologics's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Y-Biologics Change In Other Working Capital Chart

Y-Biologics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Change In Other Working Capital
Get a 7-Day Free Trial 301.77 -30.54 -823.00 2,663.90 704.94

Y-Biologics Quarterly Data
Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only - - -1,735.68 -311.84 145.79

Y-Biologics Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,902 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Y-Biologics Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Y-Biologics's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Y-Biologics (XKRX:338840) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 715, 17, Tech-ro 4-ro, Yuseong-gu, Daejeon, KOR
Y-Biologics Inc is a company has a variety of development candidate antibodies based on Korea's highest-level antibody discovery platform technology and then independently develops antibody treatments or jointly develops cutting-edge biopharmaceuticals by fusing them with our partner's platform technology. Its main business model is based on a globally competitive antibody discovery platform and consists of development of new bio drug candidates and early technology transfer, and contract research services that generate stable cash flow.

Y-Biologics (XKRX:338840) Headlines

No Headlines